Lifecore Biomedical, Inc.
LFCR· Nasdaq
Source filing unavailable
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $73.30M | $64.95M |
| Net Income | $1.81M | $2.30M |
| EPS Diluted | $0.07 | $0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR